Specialties

Study examines SGLT-2 inhibitors versus DPP-4 in reducing cardiovascular events.

Patients who have diabetes should be screened for psychological risk factors.

Younger patients with type 1 diabetes may require extra monitoring to avoid adverse glycemic events

Combined analysis of eGFR and albuminuria over 2 years has been shown to predict T2DM patients’ risk for major macrovascular outcomes.

Both patients and HCPs should be aware of early signs of kidney issues.

Studies show a link between diabetic peripheral neuropathy and sarcopenia, which increases frailty and subsequent mortality.

Patients with diabetes are two times more likely to present with symptoms of depression; how does this affect diabetes outcomes?

After starting a new medication (gabapentin) for his neuropathy, a patient of mine gained 30lbs and presented with peripheral edema without symptoms.

While cardiovascular risk factors are used to predict risk for clinical outcomes and base therapies, it may be a fluctuation in such risk factor measurements that has the most impact.

Heart failure is a common macrovascular complication that may occur in patients with diabetes, but what gender is more prone to have continuous hospitalization for heart failure problems?